Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07506044 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 13, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Recruitment opened
    • Site details revised
    v3
  2. Start date: Feb 1, 2026 to May 30, 2026v2 Show 4 more changesShow less
    • Trial status changed: Recruiting → Not Yet Recruiting
    • Primary completion pushed from Aug 1, 2026 to Oct 1, 2026
    • Study completion pushed from Aug 30, 2026 to Oct 30, 2026
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.
Trial Details
NCT Number NCT07506044
Lead Sponsor Menoufia University
Conditions
(from sponsor)		 Total Dose of Bupivacaine Administered During Labor
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov